Also listed on Sierra Oncology, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 21, 2039 · Low confidence
20-year base term ends Aug 21, 2039
Aug 21, 2019
Aug 21, 2039
Mar 17, 2026
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 21, 2019, when application PCT/US2019/047499, the earliest non-provisional in its chain, was filed (this one was filed Mar 12, 2024); a parent in its chain could not be resolved (the next row) | Aug 21, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,963,962) | resolves to Aug 21, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 17266262 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Aug 21, 2039 | Low confidence |
This family
| Application PCT/US2019/047499 | PCT application no patent term | no patent term |
| US 11,963,962 | In force Dec 2040 | Dec 2040 |
| US 12,576,089 | this patent Aug 2039 | Aug 2039 |
| Application 19/542,895 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 5, 2024 Reel 69140, frame 781 | Sierra Oncology LLC | GlaxoSmithKline LLC | Assignment of Assignor's Interest |
| Nov 5, 2024 Reel 69305, frame 750 | Sierra Oncology, Inc. | Sierra Oncology LLC | Assignment of Assignor's Interest |
| Nov 18, 2024 Reel 69304, frame 561 | Klencke, Barbara Jane; Smith, Gregg David; Donahue, Rafe Michael Joseph | Sierra Oncology, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,963,962, ends no earlier than this term, so it caps nothing.